Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,742 | 16,903 | 13,987 | 25,176 | 46,599 |
| Marketable Securities | 7,970 | 5,420 | N/A | 17,466 | 20,736 |
| Receivables | 1,913 | N/A | 8,875 | 1,482 | 1,335 |
| Inventories | N/A | N/A | N/A | 10,655 | 13,980 |
| Other current assets | 2,807 | 2,449 | 4,320 | 10,115 | 9,205 |
| TOTAL | $18,432 | $24,772 | $27,182 | $64,894 | $91,855 |
| Non-Current Assets | |||||
| PPE Net | 147 | 176 | 285 | 1,294 | 1,661 |
| Other Non-Current Assets | 11,588 | 11,954 | 34,571 | 42,910 | 49,190 |
| TOTAL | $11,735 | $12,130 | $34,856 | $44,204 | $50,851 |
| Total Assets | $30,167 | $36,902 | $62,038 | $109,098 | $142,706 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 318 | 1,762 | 1,384 | 4,367 | 2,146 |
| Accrued Expenses | 2,067 | 2,552 | 4,599 | 6,589 | 7,768 |
| Other current liabilities | 14,319 | 7,671 | 24,143 | 20,542 | 23,644 |
| TOTAL | $18,057 | $14,563 | $47,892 | $134,574 | $155,979 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,011 | 1,607 | 15,983 | 95,092 | 116,344 |
| Other Non-Current Liabilities | 48,744 | 57,380 | 69,218 | 71,807 | 76,796 |
| TOTAL | $48,744 | $57,380 | $69,218 | $71,807 | $77,266 |
| Total Liabilities | $66,801 | $71,943 | $117,110 | $206,381 | $233,245 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,210 | 7,023 | 5,961 | 5,859 | 5,760 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -2,018,459 | -2,014,156 | -2,016,543 | -2,054,553 | -2,041,860 |
| Other shareholders' equity | 2 | 0 | 0 | 8 | 22 |
| TOTAL | $-36,634 | $-35,041 | $-55,072 | $-97,283 | $-90,539 |
| Total Liabilities And Equity | $30,167 | $36,902 | $62,038 | $109,098 | $142,706 |